CHU de Nîmes - Centre de Gérontologie de Serre Cavalier
Nîmes, 30029, France
NCT Number: NCT01819714
The main objective of this study is to evaluate the effect of 3 months of "Snoezelen-type" multi-sensory care sessions on NeuroPsychiatric Inventory Questionnaire (NPI-Q) scores for patients with Alzheimer's-type neurodegenerative disease.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nîmes, 30029, France
The secondary objectives of this study are to study the following elements in relationship to the implementation of a "Snoezelen-type" multi-sensory care strategy for patients with Alzheimer's-type neurodegenerative disease:
A. to evaluate the effects on NPI-Q scores at 1 month, 6 months and 12 months .
B. evaluate the effects on quality of life (questionnaire QOL-AD) at 0 and 12 months.
C. assess changes in the "aggressive behavior" subsection of the Cohen-Mansfield Agitation Inventory (CMAI) questionnaire over 0, 1, 3, 6 and 12 months.
D. assess changes in drug consumption (anxiolytics, antidepressants, hypnotics, neuroleptics)over the study period
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Serre-Cavalier center will implement Snoezelen-type multisensory care sessions for included patients; these care sessions correspond with the patients' daily hygiene/toilette care.
The impact of this multisensory strategy will be evaluated using a before-after design.
Other names: Snoezelen-type care, Snoezelen toilette
Time frame: 3 months
Time frame: 1 month
Time frame: 6 months
Time frame: 12 months
Time frame: 12 months
Time frame: 1 month
Time frame: 3 months
Time frame: 6 months
Time frame: 12 months
Time frame: 1 month
Time frame: 3 months
Time frame: 6 months
Time frame: 12 months
Centre Hospitalier Universitaire de Nīmes
Other
Evaluation of the Impact of Care Based on Sensory Support for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative Disease
Acronym: SensiCare
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06347172
Alzheimer Disease, Brain Diseases
Boston, Massachusetts, United States
View Trial DetailsNCT04992195
Alzheimer Disease, Arterial Thromboembolism
Hong Kong
View Trial DetailsNCT05529706
Alzheimer Disease, Brain Diseases
San Francisco, California, United States
View Trial DetailsNCT04121858
Alzheimer Disease, Brain Diseases
Indianapolis, Indiana, United States
View Trial Details